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General Methods. Fmoc-protected amino acids, O-Benzotriazole-N,N,N’N’-tetramethyl-
uronium-hexafluoro-phosphate (HBTU), N-hydroxybenzotriazole (HOBt), and Wang resin were 
purchased from Novabiochem (San Diego, CA). Dimethylformamide (DMF), N-methyl-2-
pyrrolidone (NMP), N-methyl morpholine (NMM), trifluoroacetic acid (TFA) and piperdine 
(Pip) were purchased from American Bioanalytical (Natick, MA). N-Fmoc-β3-p-
iodohomophenylalanine was purchased from Peptech (Burlington, MA). All other reagents were 
purchased from Sigma-Aldrich (St. Louis, MO). Mass spectra were acquired with an Applied 
Biosystems Voyager-DE Pro MALDI-TOF mass spectrometer (Foster City, CA).  Reverse-phase 
HPLC was performed using a Varian Prostar HPLC and Vydac analytical (C8, 300 Å, 5 µm, 4.6 
mm X 150 mm) or preparative (C8, 300 Å, 5 µm, 25 mm X 250 mm) columns, using 
water/acetonitrile gradients containing 0.1% TFA. Circular dichroism (CD) spectra were 
acquired with a Jasco J-810 Spectropolarimeter (Jasco, Tokyo, Japan) equipped with a Peltier 
temperature control. Analytical ultracentrifugation (AU) was performed using a Beckman XL-I 
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instrument. Differential scanning calorimetry experiments were performed on a Microcal VP-
DSC instrument (Northhampton, MA) in the labs of Dr. Jeff Hoch at the University of 
Connecticut Health Center (Farmington, CT). 1H NMR experiments were performed on a Bruker 
500 MHz instrument. All experiments were performed in phosphate buffer (10 mM NaH2PO4, 
200 mM NaCl, pH adjusted to 7.1 with NaOH), except as noted.  
β-peptide synthesis and purification. β3-peptides were synthesized on a 25 µmole scale using 
standard Fmoc chemistry and Wang resin loaded with β3-homoaspartic acid as previously 
described.1 One cycle of peptide elongation consisted of the following steps: First, the loaded 
resin was washed with DMF (6 X 30 sec) and the terminal Fmoc protecting group removed with 
20% Pip in DMF (1 X 2 min, 2 X 8 min). This deprotection step was supplemented with a 
second deprotection step using diazabicyclo[5.4.0]undec-7-ene (DBU) after five residues have 
been attached to the resin (1 X 2 min 20% Pip/DMF, 2 X 8 min 20% Pip/DMF, 1 X 8 min 2:2:96 
Pip/DBU/DMF, and 1 X 8 min 20% Pip/DMF). After deprotection, the resin was washed with 
DMF (6 X 30 sec) and the next β3-amino acid coupling reaction was carried out for 30 min using 
2 equiv. of the appropriate β3-amino acid, 1.8 equiv. HBTU, 2 equiv. HOBt, and 5 equiv. 
diisopropylethylamine (DIEA). This coupling was the repeated with fresh reagents for another 
30 min. The resin was then washed with DMF (6 X 30 sec) before the next cycle of elongation. 
This elongation cycle was repeated until the β-peptide sequence was complete. Once the final 
Fmoc protecting group had been removed, the resin was washed with DMF (8 X 30 sec) and 
methylene chloride (8 X 30 sec), dried for 20 min under nitrogen, and treated with a cleavage 
cocktail composed of 1% v/v each of water, triisopropylsilane and phenol in TFA (2 X 60 min). 
The cleaved peptides were precipitated with 50% v/v pentane/ether. After decanting the ether 
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and drying with nitrogen, the precipitated peptides were dissolved in 30% v/v acetonitrile in 
water and purified by HPLC.  
 The success of each synthesis was assessed by both HPLC and MALDI-TOF analysis of 
the crude reaction mixture. β-peptides were then purified to homogeneity by reverse-phase 
HPLC. The identities and purities of the purified β-peptides were assessed by analytical HPLC 
and mass spectrometry. MALDI mass spectra were obtained using peptide samples in   -cyano-
4-hydroxycinnaminic acid (CHCA) matrix. The masses found were: Acid-1Y (m/z observed, 
calculated):   [M+H]+ 1685, 1683; Acid-1Y*  (m/z observed, calculated): [M+H]+ 1794, 1793 
(Figure S1).  Following purification, β-peptides were lyophilized and reconstituted in buffer 
(previously described) for characterization.  
 
Figure S1. Chemical structures of Acid-1Y and Acid-1Y*.   
Sedimentation Equilibrium Analytical Ultracentrifugation. HPLC-purified, lyophilized 
samples of Acid-1Y (300 µM, 150 µM and 75 µM) and Acid-1Y* (280 µM, 140 µM and 70 
µM) were resuspended and centrifuged at 25 oC to equilibrium at three different speeds (42,000, 
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50,000 and 60,000 rpm). Centrifugation was performed in an AN 60-Ti 4-hole rotor equipped 
with six-channel, carbon-epoxy composite centerpieces (Beckman).  Absorbance was monitored 
at 280 nm. Data were collected with a step size of 0.001 cm with scans occurring at 3 h intervals. 
Samples were determined to have reached equilibrium when no significant changes in radial 
concentration were observed in three successive scans using the program Match within the 
Heteroanalysis software suite (available from the National Analytical Ultracentrifugation Facility 
website, http://vm.uconn.edu~wwwbiotc/uaf.html). The partial specific volume of each β-peptide 
was calculated from functional group composition according to Durchschlag and Zipper.2  The 
data was fit to a monomer-n-mer equilibrium model using the Heteroanalysis software. Fixed 
parameters: Acid-1Y monomer MW = 1682 Da, v-bar = 0.7846 cm3/g, d = 1.00674 g/mL, ε280 = 
1360 M-1•cm-1, and n = 8; Acid-1Y* monomer MW = 1792 Da, v-bar = 0.7513 cm3/g, d = 
1.00674 g/mL, ε280 = 1360 M-1•cm-1, and n = 8. Fitted parameters: Acid-1Y ln Ka = 83.3 ± 1.8, 
RMSD = 0.01002 and baseline deviation <0.02; Acid-1Y* ln Ka = 65.6 ± 0.1, RMSD = 0.00708 










Figure S2. Acid-1Y self-association 
monitored by analytical 
ultracentrifugation (AU) (150 µM Acid-
1Y) and fit to monomer-n-mer equilibria 
where (A) n = 7; (B) n = 8; (C) n = 9; and 
(D) n = 10.   Samples were prepared in 10 
mM NaH2PO4, 200 mM NaCl (pH 7.1) 
and centrifuged to equilibrium at 25 oC at 
speeds of 42 (red), 50 (green), or 60 
(blue) kRPM. The experimental data 
points are shown as open circles; lines 
indicate a fit to a monomer-octamer 
model as described in the experimental section. We note that the data fit poorly to a monomer-
hexamer model (n = 6), with a RMSD significantly higher (0.2159) than the RMSD values for 
other fits including n = 7 (0.01367), n = 8 (0.00706) and n = 9 (0.01370). 
Circular Dichroism (CD). Wavelength dependent CD spectra were acquired for various 
concentrations of Acid-1Y and Acid-1Y* at 25 oC in continuous scan mode with 0.5 nm data 
pitch, 50 nm/min scanning speed, 4 sec response, 0.5 nm band width and 3 accumulations. The 
concentration dependence of the molar residue ellipticity (MRE) at 205 nm was determined by 
least-squares fitting of the total peptide monomer concentration as a function of experimental 




The values obtained for the Acid-1Y fitted parameters were MREMon = 11160 deg•cm2•dmol-1 
(constant, not fit in equation), MRENmer = 24900 ± 180 deg•cm2•dmol-1, and ln Ka. = 82.5 ± 1.8. 
The curve in Figure 2B was fit using these parameters. Wavelength-dependent CD spectra for 
Acid-1Y* also shows a concentration dependent increase in helical structure (Figure S3), 
analogous to that observed for Acid-1Y. The values obtained for the Acid-1Y* fitted parameters 
for a monomer-octamer model were MREMon = 0 deg•cm2•dmol-1 (constant, not fit in equation), 
MRENmer = 16755 ± 58 deg•cm2•dmol-1, and ln Ka = 81.1 ± 0.8. However, analyses of MRE208 as 
a function of [Acid-1Y*] were ambiguous in discriminating between monomer-hexamer and 
monomer-octamer models. To resolve this ambiguity in favor of the monomer-octamer model 
we used the results of the AU data and the crystal 
structure.  
 
Figure S3. Acid-1Y* self-association measured by 
circular dichroism spectroscopy (CD). Wavelength-







Temperature-dependent CD spectra were obtained at 205 nm between 5 and 95 oC, using the 
variable temperature module provided with the instrument. Data were collected with a 1 oC data 
pitch, 5 sec delay time, 1 oC/min temperature slope, 4 sec response time, and 1 nm band width. 
The first derivatives of the temperature-dependent CD spectra for the various concentrations of 
Acid-1Y were calculated and the Tm values reported correspond to the maximum of the 
δMRE205/δT plots. Refer to Figure 3A for a plot of the δMRE208/δT as a function of temperature 
for Acid-1Y.  
1-anilino-8-naphthalenesulfonate (ANS) Binding.  Stock solutions of 400 µM Acid-1Y were 
prepared in 10 X PBC (100 mM phosphate, borate, and citrate) supplemented with 200 mM 
NaCl, pH 7.0; a 10 µM stock of ANS was prepared in the same buffer (from an initial stock of 
20 µM ANS in 10 X PBC). Binding reactions were performed by mixing 80 µL of the ANS 
solution with an appropriate volume of the Acid-1Y stock solution and diluting to a final volume 
of 160 µL with 10 X PBC, 200 mM NaCl in order to produce 400, 200, 100, 50 and 25 µM 
solutions of Acid-1Y. Fluorescence intensity (counts/s) measurements were made using a Photon 
Technology International (Lawrenceville, NJ) Quantamaster C-60 spectrofluorimeter at 25 oC in 
a 1 cm path length Hellma (Mullheim, Germany) cuvette. The sample was excited with 350 nm 
light (4 nm slit width) and fluorescence emission was measured at 1 nm intervals between 400 
and 600 nm. ANS binding was not performed on Acid-1Y*. 
Differential Scanning Calorimetry.  Temperature scans were performed from 5 to 125 oC at a 
scan rate of 1 oC/min. with a 10 min. equilibration period at 5 and 125 oC. All scans were 
performed with an excess pressure of 40 PSI. Samples of 300 µL (142 µL sample cell) were 
injected from the autosampling tray after being held at 10 oC.  The raw data of temperature, 
power and time were converted to plots of heat capacity versus temperature. This data was fit to 
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a two-state model with dissociation of eight subunits using the program EXAM.4  This process 
involves fitting ΔHCal(T1/2), ΔCP(T1/2), ΔCP’(T1/2), T1/2, BA, BA’, BB, BB’ in the following equations 
where N and n are fixed: 
 
The fitting results are shown in Figure 3B for 300 µM Acid-1Y.  The values of the fitted 
parameters are as follows: ΔH(T1/2) = 132.0 ± 0.4 kcal•mol-1, ΔCP(T1/2) = 1.8 kcal•mol-1•K-1,  
ΔCP’(T1/2) = , T1/2 = 356.3.  The equilibrium constant at 25 °C (K = 6.1 X 10-36) was calculated 
using K(T) = 1/(K(T1/2)•e-ΔΔG/RT), where K(T1/2)= (CT/2)n/(CT/2n) and CT is the total peptide 
concentration. 
The van’t Hoff enthalpy was calculated from the integrated calorimetric enthalpy (ΔHCal*), 
obtained by integrating the area between the thermogram and the baseline in Figure 5 for Zwit-
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1F and Acid-1Y.  This area was used in the following equation to calculate the van’t Hoff 
enthalpy according to Sturtevant5 and Marky and Breslauer6: 
 
 
where CPMax is the maximum difference between the thermogram and the baseline heat capacity 
and n is the number of subunits.  The ΔHvH/ΔHCal ratio was calculated using the fitted ΔHCal(T1/2) 
from above. 
Crystallization and Structure Determination. Acid-1Y* (2.00 mM) was crystallized by 
hanging drop vapor diffusion over a buffer composed of 1.35 M sodium citrate and 0.1 M 
HEPES (pH 7.5). Crystals were cryoprotected using a step-wise transfer from mother liquor 
containing 0% glycerol to mother liquor supplemented with 7.5% glycerol and then 12% 
glycerol.  X-ray diffraction data to 1.54 Å resolution was collected at 100K at the Yale Center 
for Structural Biology.  Data was processed to 2.3 Å resolution using the HKL2000 software 
suite.7  Molecular replacement using a tetramer of the previously solved Zwit-1F octamer8 was 
used to obtain phases calculated to 2.3 Å using CNS.9  The data was determined to have partial 
merohedral twinning by the Yeate’s twinning test with a twinning fraction (α) equal to 0.307932 
± 0.004175 following a twin operation of 2 along a*, b*.10  Detwinning, density modification 
and NCS averaging were performed using CNS.9  The program XFIT was used to build and 
refine eight 314-helices into the electron density maps.11 Refinement was preformed using CNS 





Table S1. Data collection, phasing and refinement statistics 
 Acid-1Y* 
Data Collection  
Space group P32 
Cell dimensions  
       a, b, c (Å) 41.345, 41.345, 66.31 
       α, β, γ (o) 90, 90, 120 
Resolution (Å) 50 - 2.30 (2.38-2.30)a 
Rsym or Rmerge 10.2 (33.8) 
I/  I  17.10 (3.48) 
Completeness (%) 99.6 (96.9) 




Resolution (Å) 50 – 2.30 
No. reflections 10,294 
Rwork/ Rfree (%) 21.52 / 24.95 
No. atoms  
      Protein 952 
      Water 38 
B-factors  
      Protein 39.758 
      Water 32.6549 
r.m.s deviations  
     Bond lengths (Å) 0.005810 
     Bond angles (°) 0.78714 
aHighest resolution shell is shown in parenthesis 
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Deuterium Exchange NMR Studies. All spectra were acquired at 25 oC using the 
WATERGATE solvent suppression pulse sequence ZZPWG (see www.bruker.com for pulse 
sequence information). Before acquisition under the WATERGATE pulse sequence, a standard 
proton spectrum was acquired using a 1.5 mM Zwit-1F sample in a 9:1 mixture of H2O and D2O 
and the position of the water peak was determined.13 The transmitter offset (01P) was set to this 
frequency for ZZPWG acquisitions. Post processing was performed with a sfil type baseline 
correction set to 1.5 ppm and a line broadening factor of 5.0 Hz. In order to acquire deuterium 
exchange data, the Acid-1Y sample was dissolved in phosphate buffer spiked with TMSP and 
lyophilized. The lyophilized sample was resuspended in D2O at a concentration of 750 µM just 
prior to insertion into the instrument. Prior to loading the Acid-1Y sample, the spectrometer was 
locked and shimmed on a sample of Zwit-1F in 9:1 H2O/D2O in phosphate buffer. Amide 
exchange rates vary logarithmically with pD in the EX2 regime (pH < 9.5 for most α-amino acid 
proteins) and therefore the pD of the Acid-1Y samples used in the NMR studies were carefully 
monitored.14 Our experiments were confirmed to belong to the EX2 regime as previously 
determined.13 We measured the pD of our Acid-1Y NMR samples after exchange was complete 
using a pH meter (Thermo Orion Model 410, Beverly, MA) in the laboratory of Prof. Ann 
Valentine (Yale University). The samples were determined to have values of 6.80 ± 0.5 and 6.87 
± 0.5 pH units, which corresponds to corrected values of 7.20 and 7.27 pD units for Acid-1Y 
samples 1 and 2 respectively.15 The 750 µM Zwit-1F samples were also determined to have a 
corrected pD of ~ 7.2.  Protection factors were calculated using krc values derived from poly-β-
homoglycine or using α−amino acid dipeptides.13, 16, 17 The former method has been described 
previously;13 for the latter, we calculated P using krc values values derived from all α-amino acid 
dipeptides represented by the sequence of Acid-1Y (NH3+-E-L-O-Y-L-D-Y-L-O-E-L-D-COO-).  
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The most conservative calculation of P for Acid-1Y makes reference to the krc value for Glu-Leu; 
the P values calculated in this way vary by a factor of four from the P values calculated with 
reference to the krc value for poly-β-homoglycine (Table S1).  
  
Table S1. Protection factors calculated from two kex sources, poly-β-homoglycine and α−amino 
acid dipeptide (Glu-Leu) 
 Protection Factors 
kex source Peak A Peak B Peak C Peak D 
 
poly-β-homoglycine18 59000 52300 69300 20500 













Figure S4. NMR Studies of 
Zwit-1F at 750 µM 
concentration. (A) 500 MHz 
1H NMR spectra of Zwit-1F 
acquired at the indicated times 
after the lyophilized Zwit-1F 
sample was reconstituted in phosphate-buffered D2O. (B) Peak heights of the indicated 
resonances (plotted as normalized values to a peak at 6.39 ppm) are fit to exponential decays for 
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